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Abstract:  Temperature, a key climate change indicator, is expected to increase 
substantially in the Northern Hemisphere, with potentially grave implications for human 
health. This study is the first to investigate the association between the daily   
3-hour maximum apparent temperature (Tappmax), and respiratory, cardiovascular and   
cerebrovascular mortality in Copenhagen (1999–2006) using a case-crossover design. 
Susceptibility was investigated for age, sex, socio-economic status and place of death. For 
an inter-quartile range (7 °C) increase in Tappmax, an inverse association was found   
with cardiovascular mortality (−7% 95% CI −13%;  −1%) and none with respiratory   
and cerebrovascular mortality. In the cold period all associations were inverse,   
although insignificant. 
Keywords:  temperature; epidemiology; respiratory; cardiovascular; cerebrovascular; 
mortality; case-crossover 
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1. Introduction 
Anthropogenic greenhouse gas emissions are expected to raise average temperatures globally 
according to the fourth assessment report from the International Panel of Climate Change (IPCC), and 
consequently the amount of heat-related morbidity and mortality is also likely to increase in   
Denmark [1]. The evaluations of the relationship between key climate change factors, such as 
temperature, and health can help identify vulnerable populations and aid policy makers in formulating 
preventive actions [1. 
Numerous studies reported that increased temperature increased total non-accidental mortality, both 
during specific heat waves 2 and over a long time period, using modern time-series or case-crossover 
analyses 3,4. Few studies have investigated the relationship between temperature and cause-specific 
mortality 5-7 or were done in Scandinavia 8-10. A J-shaped relationship has been found between 
temperature and total non-accidental and cause-specific mortality, with high temperatures (heat) 
having an immediate (same day or previous day) effect 3,4. In a colder climate, the increase of global 
temperature may benefit health, although the wintertime increase in total non-accidental mortality may 
be due to infectious disease, and not a direct effect of cold weather [11]. However, few studies have 
investigated the relationship between decreased temperature and mortality during the colder   
seasons 12,13. The overall effect of increased temperature is assumed to depend on cause of death, 
population characteristics, and efficiency of the health care system. Vulnerability to increased 
temperature may be affected by socio-economic status (SES), age, sex, level of urbanisation, 
household characteristics and pre-existing disease status 3,4. 
Although the association between air pollution and cardiovascular disease (CVD) and respiratory 
disease (RD) mortality and morbidity is well established, air pollution has rarely been considered as 
confounder or effect modifier in studies of temperature effects 2-4. A recent review concluded that 
particulate matter less than 10 μm in aerodynamic diameter (PM10) and ozone could be both, although 
the independent effect of temperature was usually withheld in analysis taken this into account 4. 
Finally, few studies distinguished between in- and out-of-hospital deaths, which may also be   
important 14,15.  
The aim of this study was to investigate the association between the daily 3-hour maximum 
apparent temperature (Tappmax) and RD, CVD and cerebrovascular disease (CBD) mortality. 
Susceptibility by age, sex, SES and place of death (in- or out-of-hospital) was investigated. 
2. Methods 
2.1. Mortality and Hospital Admission Data 
Mortality and hospital admission data in the Copenhagen area (postal code < 2930, <15 km radius 
from the city centre, population 1 million) were retrieved from the Danish cause of death and hospital 
discharge registers, respectively. The following International Classification of Diseases 10th Revision 
(ICD 10) codes were included: CVD: angina pectoris (I20), myocardial infarction (I2122), other acute 
ischemic heart diseases (I24), chronic ischemic heart disease (I25), pulmonary embolism (I26), cardiac 
arrest (I46), cardiac arrhythmias (I48–49), and heart failure (I50); CBD: intracerebral haemorrhage 
(I61), cerebral infarction (I62) and stroke, not specified as haemorrhage or infarction (I64); RD: Int. J. Environ. Res. Public Health 2011, 8          
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chronic bronchitis (J4142), emphysema (J43), chronic obstructive pulmonary disease (J44),   
asthma (J45) and status asthmaticus (J46). 
Only primary diagnosed hospital admissions were included as outcome, but both emergency and 
planned hospital admissions were linked to the mortality dataset. A death was classified as in-hospital, 
when the hospital discharge date was the same as the date of death, and out-of-hospital when the 
hospital discharge date was at least one day before the date of death. Twelve deaths could not be 
classified due to errors in hospital discharge dates (after death). 
2.2. Meteorological and Air Pollution Data 
Meteorological and air pollution data were measured at the Copenhagen urban background 
monitoring station by the Department of Environmental Sciences, Aarhus University 16. 
Temperature and relative humidity (RH) were measured with the HMP45a probe (Vaisala, Helsinki). 
Air pollution data included 24-hour averages (from midnight to midnight) of PM10 (Beta attenuation 
by SM200 monitor; Opsis, Sweden), nitrogen dioxide (NO2) (M 200A; API, San Diego, CA, USA) 
and carbon monoxide (CO) (M 300 monitor; API). NO2 was also reported as a daily 1-hour maximum 
(NO2max). The RH measurements have a minor error probably due to the calibration, which had a 
minor impact on the calculated Tappmax. Hence this measurement error is not likely to reduce the 
validity of our results (Supplementary Figures 1 and 2). 
Barnett and colleagues concluded that there is no single temperature measure that is superior to 
others 17. We selected Tappmax as the primary exposure variable. Tappmax is a construct intended to 
reflect the physiological experience of combined exposure to humidity and temperature and thereby 
better capture the response on health than temperature alone 18. Tappmax has been applied in several 
studies 2-4. 
2.3. Influenza Data 
Influenza epidemics data were provided by the National Serum Institute as weekly percentage of 
total general physician’s consultations due to influenza in Denmark, whereas city level data were  
not available. 
2.4. Effect Modifier Data 
Addresses of the 31,342 deceased persons were retrieved by linkage with the Danish central 
population registry. A recent report was published on SES groups in Copenhagen, which classified 
communities and the inner city neighbourhoods into four SES groups (highest, second highest, second 
lowest and lowest), based on household income, educational and employment status 19. An area SES 
class was assigned to each person by linking the home street code to a geographical information 
system dataset. Nearly all (99%) of the 31,342 deceased persons lived at only one address during 
19992006. A SES class could not be assigned to 456 people due to invalid street codes. A SES code 
was assigned for the valid address at which the person lived longest. In the case of more than three 
addresses, the mode of the area SES classes at the different addresses was assigned to that person. Int. J. Environ. Res. Public Health 2011, 8          
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2.5. Ethics 
As this study was purely registry based, no human participants were recruited or included in 
experiments. Approval was granted by the proper authority, which in this case is the Danish Data  
Protection Agency. 
2.6. Statistical Analysis 
The time-stratified case-crossover design was applied to investigate the association   
between Tappmax and the cause-specific mortality (in- and/or out-of-hospital) for the   
period 1 January 199931 December 2006. The case-crossover design was developed as a variant of 
the case-control design to study the effects of transient exposures on emergency events 20. In this 
design each person’s exposure is compared in a time period just prior to a case-defining event with 
his/her exposure at other times 20. Hereby, control on all measured and unmeasured personal 
characteristics that do not vary over a short time period is accomplished. If in addition, the control days 
are chosen close to the event day, personal characteristics that vary slowly over time are also 
controlled by matching. A time-stratified approach was applied to select the control days, defining the 
day of death as the case day and same day of the week in the same month and year as control days. 
Hence, for example, if someone died on 16 February 2000, then the control days would have been  
the 2, 9, 23 February 2000. With this approach even very strong confounding of exposure by seasonal 
patterns is controlled by design 21-24. The association between Tappmax and the cause-specific 
mortality were investigated using conditional logistic regression analysis (PROC PHREG in SAS 9.2, 
SAS Institute, Cary, NC, USA).  
Models were first stratified by seasonal period (warm or cold). Public holidays were controlled for 
as a dichotomous variable and influenza as a continuous variable. A previous study in Copenhagen 
reported a linear relationship between the air pollutants and the cause-specific admissions for the 
period 19992004 25. The pollutants were therefore modeled as linear terms, one pollutant at a time. 
During 19992006 there were 569 and 114 days with missing values for the pollutants and 
meteorological variables, respectively, with a total of 625 days with missing data out of 2,922. 
Individual lags of lag0 (same day exposure as day of death) to lag5 (exposure five days prior to day 
of death) of Tappmax were investigated, as well as accumulated exposures: mean of lag0–1 (2-day 
simple unweighted cumulative average, CA2), and up to mean lag0–5 (CA6). Control days for lag1 to 
5 were defined as for lag0. The same lag of Tappmax and an air pollutant was included in a model.  
There is no standard method to select a lag 26. We selected the lag of Tappmax with the lowest 
Akaike Information Criterion (AIC) and applied that in the stratified models. In general, the lowest 
AIC model had the strongest association (i.e., highest absolute association measure) between Tappmax 
and a cause-specific outcome.  
A large European study observed associations between mortality and longer lags of up to CA15 for 
the cold period 13. Hence, longer lags of up to CA15 for the cold period were also investigated in  
our study.  
Hazard ratios (HR) and the 95% confidence intervals (CI) were calculated per inter-quartile range 
(IQR) increase in Tappmax (in °C). The results are presented as the percent excess risk in cause-specific Int. J. Environ. Res. Public Health 2011, 8          
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mortality per IQR increase in Tappmax using the following calculation: β
(HR – 1)  100%, where β is the 
model estimate. 
Due to the nature of the case-crossover design where each person is his/her own control, 
susceptibility cannot be investigated by including an interaction term between the susceptibility 
variable and Tappmax. Susceptibility was therefore investigated in stratified analyses by sex, age and 
SES groups. Age was categorised as 1965, 6680 and >80 years. 
Sensitivity analyses were applied. The linearity and strength of the association between Tappmax and 
a cause-specific outcome were substantiated in generalised additive Poisson time-series regression 
models (GAM) with the use of the gam  procedure,  mgcv  package in R statistical software (R 
Development Core Team, 2010). Models were run with linear and non-linear terms for Tappmax, as a 
natural smoothing spline function with five degrees of freedom (df). Smoothing splines of calendar 
time (4 df/year) were used to control for long-term trend and seasonality. A spline function, defined by 
piecewise polynomials, has a flexible shape that is useful for adjusting for non-linear effects. The 
smoothness of a spline is a function of the number of degrees of freedom. We investigated whether the 
non-linear term for Tappmax improved the models by conducting log-likelihood ratio tests. 
Unmeasured, unknown and potentially variable seasonal and long term patterns need to be controlled 
for adequately in GAM models, whilst still leaving sufficient information from which to estimate 
temperature effects. Other sensitivity analyses included applying the 24-hour average temperature 
(Tave) as an alternative temperature definition, whilst also adjusting for the 24-hour average RH, public 
holidays and influenza epidemic.  
3. Results 
The statistical analyses are based on 2,922 days with 5,973 RD, 18,816 CVD and 6,558 CBD 
deaths. Table 1 displays a summary of the meteorological conditions, air pollution levels and influenza 
epidemics during 19992006. None of the EU air quality limit values (PM10 40 μg.m
-3 (annual), NO2 
21 ppb (annual), CO 5.3 ppm (1-hour max)) were exceeded at the urban background level, but PM10 
and NO2 limit values were exceeded at street level (not shown) 27. 
Table 1. Summary statistics for cause-specific mortality, air pollutant levels and 
meteorological conditions in Copenhagen and weekly general practice visits due to 
influenza in Denmark during 1 January 199931 December 2006. 
  All year  Warm period  Cold period 
Number of days  2,922  1,464  1,458 
Respiratory deaths        
 Mean  SD  2  2  2  1  2  2 
 Range  010 07 010 Int. J. Environ. Res. Public Health 2011, 8          
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Table 1. Cont. 
  All year  Warm period  Cold period 
Cardiovascular deaths       
 Mean  SD    6  3  6  3    7  3 
 Range    018 015    018 
 Cerebrovascular deaths       
 Mean  SD    2  2  2  2    2  2 
 Range    010 09    010 
Tappmax (C)      
 Number of days with 
 missing data 
  114  32    82 
 Mean  SD    10  8  16  6    4  5 
 Range  −830 030  −818 
 Percentiles       
 25th    3  12    0 
 50th    9  16    3 
 75th    16  20    7 
 Inter-quartile range    13  8    7 
PM10 (µg/m
3)      
 Number of days with 
 missing data 
  454  266    188 
 Mean  SD    27  16  27  14    28  17 
 Range    0284 1284    0248 
NO2 (ppb)       
 Number of days with 
 missing data 
  164  109    55 
 Mean  SD    12  5  11  4    13  5 
 Range    241 333    241 
NO2max (ppb)       
 Number of days with 
 missing data 
  137  97    40 
 Mean  SD    22  9  21  10    23  9 
 Range    478 478    560 
CO (ppm)       
 Number of days with 
 missing data 
  129  81    48 
 Mean  SD    0.28  0.10  0.23  0.07    0.33  0.10 
 Range    0.080.92 0.080.58    0.130.92 
Weekly GP visits due to 
influenza in Denmark (%) 
   
 Number of weeks with 
 missing data 
  0  0    0 
 Mean  SD    1.12  1.50  0.28  0.61    1.96  1.65 
 Range    09.70 03.40    09.70 
SD: Standard deviation; GP: General practitioner. 
 Int. J. Environ. Res. Public Health 2011, 8          
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The majority of deaths were due to CVD, followed by CBD and RD, with more deaths during the 
cold period (Table 1). The majority of in-hospital RD, CVD and CBD deaths occurred after emergency 
hospital admissions: 93%, 97% and 96%, respectively. Half of the RD and CBD deaths occurred  
in-hospital, whilst 66% of CVD deaths were out-of-hospital (Table 2). Regardless of place of death, 
the majority of RD deaths were due to chronic obstructive pulmonary disease. In-hospital CVD deaths 
were mostly due to acute health outcomes compared to out-of-hospital CVD deaths. Regardless of 
place of death, the majority of the CBD deaths were due to stroke, not specified as haemorrhage  
or infarction. 
Table 2. Summary statistics for specific types of respiratory, cardiovascular and 
cerebrovascular deaths, by place of death during 1 January 1999–31 December 2006. 
  In-hospital 
deaths 
Out-of-hospital 
deaths 
Total * 
  No. %  No. %  No. % 
Repiratory deaths  3,089 100.0 2,883 100.0 5,973 100.0 
 Simple and mucopurulent chronic  
 bronchitis 
0 0.0  7 0.2  7 0.1 
 Unspecified chronic bronchitis  156  5.1  313  10.9  469  7.9 
 Emphysema  44  1.4  73  2.5  117  2.0 
 Chronic obstructive pulmonary  
 disease 
2,857 92.5  2,192 76.0  5,049 84.5 
 Asthma  26  0.8  288  10.0  314  5.3 
 Status astmaticus  6  0.2  10  0.3  16  0.3 
Cardiovascular deaths  6,310 100.0 12,502  100.0 18,816  100.0 
 Angina pectoris  26  0.4  61  0.5  87  0.5 
 Acute myocardial infarction  2,517  39.9  3,064  24.5  5,581  29.7 
 Subsequent myocardial infarction  154  2.4  165  1.3  319  1.7 
 Other acute ischemic heart diseases  8  0.1  8  0.1  16  0.1 
 Chronic ischemic heart disease  1,387 22.0  5,244 41.9  6,631 35.2 
 Pulmonary embolism  337  5.3  304  2.4  641  3.4 
 Cardiac arrest  143  2.3  1,013  8.1  1,156  6.1 
 Atrial fibrillation and flutter  544  8.6  496  4.0  1,040  5.5 
 Other cardiac arrhythmias  27  0.4  92  0.7  119  0.6 
 Heart failure  1,167  18.5  2,055  16.4  3,222  17.1 
Cerebrovascular deaths  3,469 100.0 3,082 100.0 6,558 100.0 
 Intracerebral haemorrhage  1,128 32.5  389  12.6  1,517 23.1 
 Cerebral infarction  595  17.2  345  11.2  940  14.3 
 Stroke, not specified as haemorrhage 
 or infarction 
1,746 50.3  2,348 76.2  4,094 62.4 
Total  12,868   18,467   31,347  
* One, four and seven RD, CVD and CBD deaths could not be classified as in- or out-of-hospital deaths, due to errors 
in hospital discharge dates (after death). Int. J. Environ. Res. Public Health 2011, 8          
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Supplementary Figure 3 indicates the average number of cause-specific deaths per Tappmax (lag0). 
We did not observe a Tappmax threshold in Copenhagen for which a minimum number of   
cause-specific deaths occurred. We therefore split a year into a warm and cold period. The warm and 
cold periods were defined as April–September and October–March, respectively, as for in other 
European cities [2,4,18,28]. Below 9 C most days were in the cold period and at 9 C or above most 
days were in the warm period (Supplementary Figure 4). So overlap of Tappmax in the warm and cold 
periods was minimal. 
CA6 of Tappmax was selected as lag and applied in the stratified models (Supplementary   
Figure 5). In general no significant associations were observed between the air pollutants and RD, 
CVD or CBD mortality during 19992006; specifically not for the selected lag of Tappmax, i.e., CA6. 
(Supplementary Figures 6 and 7). Consequently the models were not adjusted for any of the air 
pollutants (Tables 3 and 4). The air pollutant models were adjusted for Tappmax (same lag as pollutant), 
public holidays and influenza. 
An IQR increase in the CA6 of Tappmax in the warm period was associated with an insignificant 
increase of 6% in RD mortality (Table 3). For an IQR increase in the CA6 of Tappmax there was a 
significant decrease of 7% in CVD mortality during the warm period (Table 3). The association 
between Tappmax and CVD mortality was stronger for those >80 years and those in the lowest   
SES group. There was no association between the CA6 of Tappmax in the warm period and CBD  
mortality (Table 3).  
In the cold period, the associations with the CA6 of Tappmax were inverse, yet insignificant   
(Table 4). However, for RD the association reached significance for out-of-hospital deaths. For   
CVD and CBD, the association with Tappmax reached significance in the highest and lowest SES  
groups, respectively.  
The effect estimate of the subgroup analyses had a wide 95% CI due to the small sample sizes. The 
direction of the observed associations was confirmed in the GAM analyses (Table 5). The   
parameter estimates for the confounders (influenza, public holiday) were similar in the GAM and  
case-crossover analyses.  
We did not find any evidence of a significant delayed effect after 6 days cumulative exposure in the 
cold period (Figure 1). The effect of cold on RD and CBD mortality appears to be stronger after 6 days 
cumulative exposure (CA6), but did not reach significance. We thus reported results for only up   
to CA6. 
Tave had similar associations with cause-specific mortality than Tappmax, with or without adjusting 
for 24-hour average RH (Supplementary Figures 810). Int. J. Environ. Res. Public Health 2011, 8          
 
3720
Table 3. Association between Tappmax (in C) and mortality, by cause of death, expressed as percentage increase in risk (%) and 95% 
confidence intervals per inter-quartile increase in the 6-day cumulative average of Tappmax (in C) during warm period of 1 January 1999 
31 December 2006 in Copenhagen. 
 Respiratory  disease  Cardiovascular disease  Cerebrovascular disease 
  IQR  n  %  95% CI  IQR  n  %  95% CI  IQR  n  %  95% CI 
All  7  2,431    6.3  -5.4 19.4  7  7,976  -6.9  -12.7  -0.6  7  2,834    2.0  -8.6 13.8 
                      
Age categories                      
  65 years  8  234  -3.7  -36.5  46.1  7  871    7.5  -11.3    30.4  7  249    21.3  -16.7 76.7 
 66–80 years  7  1,145    5.3  -11.1 24.8  7  2,225  -9.0  -19.5    2.9  7  788    7.1  -12.8 31.6 
 > 80 years  8  1,052    12.3  -8.4 37.6  7  4,880  -8.3  -15.7  -0.4  7 1,797  -2.6  -15.2 11.9 
                      
Sex                      
 Women  7  1,422    1.0  -13.3 17.7  7  4,286  -4.9  -13.0    3.9  7  1,780    1.0  -12.2 16.2 
 Men  8  1,009    16.3  -5.2 42.8  7  3,690  -9.1  -17.4    0.0  7  1,054    3.9  -13.0 24.0 
                      
Socio-economic 
status                      
 Lowest  7  882    4.8  -13.7 27.4  7  2,667  -11.2  -20.7  -0.6  7  876    13.6  -6.8 38.3 
 Second lowest  8  677  -12.5  -31.9 12.4  7  2,000  -6.7  -17.9    6.0  7  725  -5.4  -23.7 17.4 
 Second highest  8  572    30.2  -0.7 70.7  8  2,166  -1.5  -14.7    13.6  7  801  -10.5  -27.3 10.2 
 Highest  8  265    20.8  -19.6 81.5  7  1,034  -7.0  -22.5    11.6  8  396    16.0  -17.5 63.1 
                      
Place of death                      
 In-hospital  8  1,242    1.1  -16.0 21.7  7  2,629  -9.4  -19.1    1.4  7  1,488  -7.0  -20.2 8.4 
 Out-of-hospital  7  1,188    12.1  -5.1 32.5  7  5,345  -5.6  -12.8    2.2  7  1,342    11.5  -4.8 30.7 
* Adjusted for day of the week, public holidays and influenza rates. Int. J. Environ. Res. Public Health 2011, 8          
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Table 4. Association between Tappmax (in C) and mortality, by cause of death, expressed as percentage increase in risk (%) and 95% 
confidence intervals per inter-quartile increase in the 6-day cumulative average of Tappmax (in C) during cold period of 1 January 1999 
31 December 2006 in Copenhagen. 
 Respiratory  disease  Cardiovascular disease  Cerebrovascular disease 
  IQR  n  %  95% CI  IQR  n  %  95% CI  IQR  n  %  95% CI 
All  6 2,854  -4.8  -13.9   5.4  6  8,777  -2.7  -8.2   3.1 6  3,010  -2.5  -11.7    7.6 
Age categories                          
  65 years  6  318    4.7  -22.7   41.8  6  927  -13.7  -28.0   3.5  7  221    26.1  -15.5    88.1 
 66–80 years  6  1,349    1.9  -12.1   18.2  6  2,415    5.9  -5.2   18.2  6  885 -1.6  -18.1    18.1 
 > 80 years  6  1,187  -13.4  -25.9   1.2  6  5,435  -4.5  -11.3   2.8  6  1,904  -5.7  -16.8    6.8 
Sex                          
 Women  6  1,720  -1.7  -13.6   12.0  6  4,769  -0.3  -7.8   7.9 6  1,970  -0.3  -11.9    12.8 
 Men  6  1,134  -9.3  -22.8    6.5  6  4,008  -5.6  -13.3   2.9  6  1,040  -6.0  -20.3    10.8 
Socio-economic 
status                          
 Lowest  6  1,034  -6.2  -20.2    10.4  6  2,996  -2.1  -11.3    8.1  6  937  -19.2  -32.4  -3.5 
 Second lowest  6  744  -1.2  -19.7    21.5  6  2,121    0.5  -10.7    13.0  6  807    11.8  -7.6    35.3 
 Second highest  6  701  -10.8  -27.2    9.4  6  2,362    0.3  -10.3    12.1  6  806  -2.8  -19.9    17.8 
 Highest  6  341    4.5  -22.1    40.2  6  1,144  -16.2  -28.5  -1.7  6  419    11.1  -14.3    44.2 
Place of death                          
 In-hospital  6  1,494    5.0  -8.7    20.7  6  2,978  -6.8  -15.6    2.8  6  1,603  -4.5  -16.6    9.2 
 Out-of-hospital  6  1,360  -14.4  -26.0  -0.9  6 5,797  -0.6  -7.4    6.8  6  1,406    0.0  -13.5    15.7 
* Adjusted for day of the week, public holidays and influenza rates. 
Table 5. Association between Tappmax (in C) and mortality, by cause of death, expressed as percentage increase in risk (%) and 95% 
confidence intervals per inter-quartile increase in the 6-day cumulative average of Tappmax (in C) during 1 January 1999  31 December 2006 
in Copenhagen.: Generalised additive Poisson time-series regression models. 
  Respiratory disease Cardiovascular disease Cerebrovascular disease
  IQR n*  % 95%  CI IQR n % 95%  CI IQR n % 95% CI
Warm 7  1,342    3.3 -5.4  12.8 7 1,342 -4.4  -8.9  0.4 7 1,342 -1.3 -9.1 7.2 
Cold 6  1,271  -8.0 -14.1 -1.5 61 , 2 7 1 -7.5  -10.9 -4.0 61 , 2 7 1 -0.9 -7.3 6.0 
Models adjusted for calendar time (4 df/year), day of the week, public holidays and influenza rates. 
* Number of days in GAM. Fewer days than in Table 1 due to missing data for 6-day cumulative average of Tappmax. Int. J. Environ. Res. Public Health 2011, 8          
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Figure 1. Percentage change (95% CI) in cause-specific mortality in Copenhagen per inter-
quartile range increase in Tappmax during the cold period* (1 January 1999 
31 December 2006), adjusted for public holidays and influenza. 
 
* Cold period: OctoberMarch. 
4. Discussion 
We evaluated associations between Tappmax and RD, CVD and CBD mortality in Copenhagen for 
the period 19992006. We found an apparent modest effect of increasing temperature on six subtypes 
of RD mortality of 0.9% per 1 C increase in the warm period. Swedish and Norwegian studies 
reported stronger associations between total RD mortality (all ICD10 codes J and any place of death) 
and the average daily temperature (Tave) > 11 C (4.3% per 1C increase) and >10 C (4.7% per 1 C 
increase in Tave over the last 7 days), respectively 8-10. An aggregated analysis of North-Continental 
cities in Europe reported 6% increase in total RD mortality per 1 C in Tappmax above the city specific 
threshold 29,30. Our lag structure with main apparent effects on RD mortality occurring within   Int. J. Environ. Res. Public Health 2011, 8          
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5 days and increased susceptibility among the elderly corroborates the findings of North-Continental 
European cities 29,30. 
We observed an inverse association between Tappmax and the 10 subtypes of CVD mortality in the 
warm period: -1.0% per 1 C increase or alternatively, 1.0% per 1 C decrease. A Swedish study 
reported a weak yet positive association between total CVD mortality (all ICD10 codes I, and any 
place of death) and Tave > 11 C (1.1% per 1 C increase) 10. In the North-Continental European 
cities total CVD mortality increased by 2% with Tappmax 29,30. Of these cities only Dublin showed 
an apparently protective effect of high temperature on total mortality. Copenhagen and Dublin have 
quite a similar climate in the warm period 29 and it is possible that cool and rainy weather have more 
adverse effect on CVD mortality than the few high temperature surges. 
The lack of association between Tappmax and the three subtypes of CBD mortality in the warm 
period in Copenhagen is consistent with the findings from a large multinational European study 29. 
We observed signs of protective effects of high temperature on all three causes of mortality during the 
cold season, consistent with other studies 5,8,12-14.  
We did not observe a Tappmax threshold in Copenhagen for which a minimum number of   
cause-specific deaths occurred (Supplementary Figure 3). However, the weight (number of days) of 
each Tappmax is different and is taken into account in regression analyses. An insignificant linear 
negative and positive relationship between RD deaths, and Tappmax was observed during the cold and 
warm periods, respectively. For CVD deaths a negative relationship was observed during both periods, 
although insignificant in the cold period. However, these weak associations are related to the absolute 
Tappmax, whereas our case-crossover study focuses on short-term Tappmax deviations (between case 
and control days) within a limited period of one month. 
Studies investigating susceptibility, other than age, of the temperature and cause-specific mortality 
relationship are scarce. We did not observed any significant adverse effect of Tappmax on RD and CBD 
mortality by age, gender, SES or place of death in the warm period. For CVD mortality, the elderly 
and lowest SES group were more susceptible to increases in Tappmax in the warm period. Other studies 
reported a stronger association between total non-accidental mortality and increased temperature 
during specific heat waves and ordinary periods among the elderly, lower SES groups and   
women 6,15,31. Total non-accidental mortality includes deaths from a broad spectrum of causes with 
probable variability in sensitivity. A study that focused on extreme heat events reported a rapid 
increase in out-of-hospital non-accidental  deaths, especially amongst the oldest groups 14 No 
extreme or long-lasting heat waves occurred in Copenhagen during 19992006 and this might be a  
possible reason why we did not observe an increase of out-of-hospital cause-specific deaths with   
increasing Tappmax. 
The underlying mechanisms for increases in RD, CVD and CBD deaths after exposure to high 
temperatures may be due to blood flow shifts to subcutaneous areas and away from the vital organs, in 
an effort to cool the body 2-4. Increased blood viscosity due to dehydration, elevated cholesterol 
levels and a higher sweating threshold in the elderly may trigger heat-related mortality in susceptible 
individuals. Factors that hamper sweating, such as high ambient humidity, reduced air currents or 
anticholinergic drugs reduce resistance to high temperature 2,4. Int. J. Environ. Res. Public Health 2011, 8          
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Various mechanisms are proposed to explain the increase in CVD and CBD mortality with 
decreasing temperatures in the cold season, such as an increase in platelet and red cell counts, blood 
viscosity and arterial pressure 32. Elderly and the lowest SES groups are likely to be particularly 
susceptible to such cold effects compatible with our data for CBD, whereas our data on CVD showed 
different patterns. 
Although we found no significant association between any of the air pollutants (for CA6) and 
cause-specific mortality, the effect estimates for lag0 of PM10 (per 10 μg·m
-3 increase) and RD and 
CVD mortality in the cold and warm periods are similar to those of the latest meta-analysis (all year): 
1.3% (95% CI 0.05%; 0.2%; pooled 18 European studies) and 0.9% (95% CI 0.05%; 1.3%; pooled 17 
European studies), respectively 26. Our 95% CIs are wider though. A significant association between 
PM10 and all cause mortality were observed for only 12 of the 33 urban centres used in the PM10  
meta-analysis. PM10 was found to be an effect modifier in Australia and a confounder in Mexico and in 
regions throughout the United States, especially in the summer 4. None of the other Scandinavian 
studies considered air pollutants as confounders or effect modifiers 8-10. 
We did not find any evidence of a significant delayed effect after 6 days cumulative exposure to 
outdoor Tappmax in the cold period, contrary to a large European study that observed associations up to 
CA15 13. Possible reasons for this inconsistency may be differences in population demographics, 
exposure conditions and the efficiency of the health care system. 
Advantages of our study include accurate data on meteorological, air pollution and health outcome 
data 33,34. Some disease misclassification is possible, but it is unlikely to be related to temperature. 
Another advantage is that similar results were in general observed for the association in the   
case-crossover and GAM analyses. The case-crossover design has some advantages over the Poisson 
time-series design. In Poisson time-series regression analysis, the population at risk must be very large 
relative to the daily number of events and the composition and size of the population at risk must not 
co-vary with the exposure of interest. The later assumption may not be fully met whenever the 
susceptible portion of the total population at risk may be increased by the cumulative effects of prior 
exposures or decreased by the adverse effects of prior exposures (harvesting). The case-crossover 
design avoids both problems as the outcome is on an individual level and not a population level (daily 
number of events). 
One study limitation is the assumption that the outdoor temperature, humidity and air pollution 
measured at one site is the same across Copenhagen or even the same for each person. It is anticipated 
that such misclassification is more pronounced among the elderly and other frail groups who generally 
spend most of their time indoors. This misclassification is non-differential and should bias the effect 
estimates towards the null. Another limitation is that ozone data were missing for a large number of 
days in the period 19992006 and were thus not used in the analyses. Ozone is a potentially important 
confounder to heat effects 4. 
Our results support the notion that moderate changes in ambient temperature are associated with 
impacts on human health even in a cool temperate climate. This association (assumed to be causal) is 
complex and depends on the specific health outcome (death or hospital admission), population 
characteristics (age, sex, SES), exposure conditions and the efficiency of the health care system, which 
all vary with time 1. The results of this and many similar studies on temperature (and other key 
climate change factors) and health can thus not be extrapolated infinitely into the future without Int. J. Environ. Res. Public Health 2011, 8          
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considering major uncertainties regarding changes in populations, the rate and intensity of projected 
climate change and adaptation, as stressed by the IPCC 1. 
5. Conclusions 
A moderate temperature increase had a protective effect on CVD mortality and hinted towards a 
slight increase in RD mortality during the warm period. In the colder months only protective effects 
were observed, although not statistically significant. Our results confirm that not only heat waves, but 
even moderate changes in ambient temperature in a Scandinavian city are associated with certain 
cause-specific mortality. 
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